In March 2025, the company announced new designs for the immediate-to-purchaser supplying of its Wegovy weight loss drug. The company founded a whole new pharmacy, called NovoCare, which might demand customers $499 per 30 days for usage of the drug, below 50 % the expense of the drug through other pharmaceutical distribution networks.[fifty three]E